Laurynas Mockeliunas

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Mockeliunas, Laurynas; Van Wijk, Rob C; Upton, Caryn M.; Peter, Jonathan et al.

Ingår i Vaccines, 2024

• DOI för Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic
• Ladda ner fulltext (pdf) av Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

Van Wijk, Rob C; Mockeliunas, Laurynas; Upton, Caryn M. M.; Peter, Jonathan et al.

Ingår i CPT, s. 1250-1261, 2023

• DOI för Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling
• Ladda ner fulltext (pdf) av Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Keutzer, Lina; Mockeliunas, Laurynas; Sturkenboom, Marieke G. G.; Bolhuis, Mathieu S. et al.

Ingår i Pharmaceuticals, 2023

• DOI för Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
• Ladda ner fulltext (pdf) av Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Mockeliunas, Laurynas; Faraj, Alan; Van Wijk, Rob C; Upton, Caryn M. et al.

Ingår i Frontiers in Pharmacology, 2023

• DOI för Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
• Ladda ner fulltext (pdf) av Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Van Wijk, Rob C; Mockeliunas, Laurynas; van den Hoogen, Gerben; Upton, Caryn M. et al.

Ingår i Scientific Reports, 2023

• DOI för Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
• Ladda ner fulltext (pdf) av Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Mockeliunas, Laurynas; Van Wijk, Rob C; Upton, Caryn M.; Peter, Jonathan et al.

Ingår i Vaccines, 2024

• DOI för Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic
• Ladda ner fulltext (pdf) av Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic

Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

Van Wijk, Rob C; Mockeliunas, Laurynas; Upton, Caryn M. M.; Peter, Jonathan et al.

Ingår i CPT, s. 1250-1261, 2023

• DOI för Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling
• Ladda ner fulltext (pdf) av Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling

Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Keutzer, Lina; Mockeliunas, Laurynas; Sturkenboom, Marieke G. G.; Bolhuis, Mathieu S. et al.

Ingår i Pharmaceuticals, 2023

• DOI för Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
• Ladda ner fulltext (pdf) av Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Mockeliunas, Laurynas; Faraj, Alan; Van Wijk, Rob C; Upton, Caryn M. et al.

Ingår i Frontiers in Pharmacology, 2023

• DOI för Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
• Ladda ner fulltext (pdf) av Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development

Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Van Wijk, Rob C; Mockeliunas, Laurynas; van den Hoogen, Gerben; Upton, Caryn M. et al.

Ingår i Scientific Reports, 2023

• DOI för Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
• Ladda ner fulltext (pdf) av Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19

Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial

Upton, Caryn M.; Van Wijk, Rob C; Mockeliunas, Laurynas; Simonsson, Ulrika S. H. et al.

Ingår i eClinicalMedicine, 2022

• DOI för Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial
• Ladda ner fulltext (pdf) av Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double- blind, randomised, controlled, phase 3 trial

Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis

Mockeliunas, Laurynas; Keutzer, Lina; Sturkenboom, Marieke G. G.; Bolhuis, Mathieu S. et al.

Ingår i Pharmaceutics, 2022

• DOI för Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
• Ladda ner fulltext (pdf) av Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis